pancreatic carcinoma (Cancer)
Information
- Disease name
- pancreatic carcinoma
- Disease ID
- DOID:4905
- Description
- "A pancreas cancer that derives_from epithelial cells located_in the exocrine pancreas." [url:http\://en.wikipedia.org/wiki/Carcinoma, url:http\://www.cancer.gov/cancertopics/types/pancreatic]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03745794 | Active, not recruiting | Phase 2 | Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery | February 28, 2019 | March 31, 2023 |
| NCT04905082 | Active, not recruiting | N/A | HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics | December 30, 2021 | June 30, 2024 |
| NCT02009449 | Active, not recruiting | Phase 1 | A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors | November 15, 2013 | August 25, 2024 |
| NCT04602026 | Active, not recruiting | N/A | The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer | September 14, 2020 | December 31, 2024 |
| NCT02432963 | Active, not recruiting | Phase 1 | Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy | June 14, 2016 | December 31, 2024 |
| NCT02465060 | Active, not recruiting | Phase 2 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | August 17, 2015 | December 31, 2025 |
| NCT04505553 | Active, not recruiting | Phase 2 | Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer | June 1, 2021 | September 30, 2024 |
| NCT02676349 | Active, not recruiting | Phase 2 | Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) | October 13, 2016 | October 2027 |
| NCT04082455 | Active, not recruiting | N/A | Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer | April 1, 2018 | June 1, 2024 |
| NCT03164486 | Active, not recruiting | Early Phase 1 | First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide | November 2016 | December 2024 |
| NCT03267524 | Active, not recruiting | N/A | Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers | November 9, 2017 | November 28, 2024 |
| NCT03752398 | Active, not recruiting | Phase 1 | A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) | May 1, 2019 | September 2025 |
| NCT03849469 | Completed | Phase 1 | A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors | May 29, 2019 | February 16, 2023 |
| NCT03645148 | Completed | Phase 1 | Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer | October 24, 2017 | April 1, 2021 |
| NCT00892736 | Completed | Phase 1 | Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy | April 20, 2009 | May 19, 2017 |
| NCT05171517 | Completed | Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy | January 1, 2022 | April 30, 2023 | |
| NCT01262040 | Completed | N/A | Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | December 14, 2010 | October 29, 2018 |
| NCT02683824 | Completed | Early Phase 1 | Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers | January 12, 2016 | December 1, 2022 |
| NCT01774019 | Completed | N/A | Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer | February 20, 2013 | December 13, 2021 |
| NCT04902144 | Completed | N/A | Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | August 3, 2020 | December 31, 2021 |
| NCT00423254 | Completed | Phase 1 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | February 2007 | November 2009 |
| NCT02807844 | Completed | Phase 1/Phase 2 | Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies | June 29, 2016 | June 4, 2020 |
| NCT03962478 | Completed | N/A | Combined Stent Insertion and HIFU Ablation for Pancreatic Carcinoma With Biliary Obstruction | May 31, 2019 | September 28, 2020 |
| NCT03949933 | Completed | N/A | Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer | May 1, 2015 | October 31, 2016 |
| NCT02517268 | Completed | N/A | Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer | June 24, 2015 | March 28, 2019 |
| NCT03554434 | No longer available | An Expanded Access Program for AM0010 (Pegilodecakin) | |||
| NCT06080854 | Not yet recruiting | Phase 2 | AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer | November 10, 2023 | June 6, 2026 |
| NCT06271291 | Not yet recruiting | Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts | July 1, 2024 | July 1, 2029 | |
| NCT03785743 | Recruiting | N/A | Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma | March 1, 2019 | May 1, 2027 |
| NCT06388967 | Recruiting | Pancreatic Cancer Detection Consortium | March 15, 2023 | November 21, 2025 | |
| NCT03747588 | Recruiting | N/A | The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer | December 1, 2018 | December 30, 2028 |
| NCT04965311 | Recruiting | Phase 2 | Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy | March 1, 2023 | May 1, 2025 |
| NCT05058846 | Recruiting | Pilot Study of Pancreatic Cancer Screening | January 20, 2022 | January 31, 2032 | |
| NCT05497531 | Recruiting | N/A | Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers | September 7, 2022 | October 2024 |
| NCT05554367 | Recruiting | Phase 2 | Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial | December 13, 2023 | August 26, 2026 |
| NCT05613465 | Recruiting | N/A | Adjuvant Chemotherapy Plus Codonopsis Pilosula Nnannf /Placebo | October 25, 2022 | December 30, 2024 |
| NCT05627427 | Recruiting | Phase 2 | Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy | July 1, 2022 | December 31, 2024 |
| NCT05634564 | Recruiting | Phase 2 | Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer | June 1, 2020 | December 31, 2023 |
| NCT05642962 | Recruiting | Phase 1/Phase 2 | Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) | November 30, 2022 | November 30, 2024 |
| NCT05830019 | Recruiting | N/A | Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery | June 1, 2021 | December 31, 2024 |
| NCT06084013 | Recruiting | Use Of Indocyanine Green In Pancreas Surgery | June 10, 2024 | February 2025 | |
| NCT06115499 | Recruiting | Phase 2/Phase 3 | The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer | December 6, 2023 | December 9, 2029 |
| NCT06168812 | Recruiting | Phase 2 | A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer | December 5, 2023 | December 5, 2025 |
| NCT06172478 | Recruiting | Phase 2 | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | February 26, 2024 | April 30, 2026 |
| NCT03711890 | Recruiting | N/A | Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer | March 26, 2019 | December 31, 2023 |
| NCT04147494 | Recruiting | Early Phase 1 | Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues | November 5, 2019 | October 17, 2031 |
| NCT04239573 | Recruiting | N/A | Comparing Two Methods to Follow Patients With Pancreatic Cysts | June 16, 2020 | July 15, 2033 |
| NCT01330823 | Suspended | Phase 3 | L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN) | June 2006 | July 2010 |
| NCT03118349 | Terminated | Phase 1 | Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy | June 1, 2017 | April 11, 2018 |
| NCT02687230 | Terminated | Phase 1 | Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1 | July 11, 2016 | May 5, 2017 |
| NCT05193604 | Terminated | Phase 1 | A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | March 24, 2022 | November 27, 2023 |
| NCT03137706 | Terminated | Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer | November 14, 2016 | October 19, 2020 | |
| NCT00907166 | Terminated | Phase 1/Phase 2 | A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients | May 2009 | December 2017 |
| NCT05237193 | Unknown status | A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up | September 3, 2021 | March 2024 | |
| NCT02285660 | Unknown status | N/A | Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition | June 2011 | December 2014 |
| NCT02839954 | Unknown status | Phase 1/Phase 2 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | July 2016 | July 2018 |
| NCT03302403 | Unknown status | N/A | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors | December 29, 2017 | December 12, 2023 |
| NCT02587689 | Unknown status | Phase 1/Phase 2 | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | October 2015 | October 2018 |
| NCT04870034 | Withdrawn | Early Phase 1 | Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer | January 15, 2024 | September 30, 2026 |
| NCT01814631 | Withdrawn | Endoscopic Ultrasound (EUS) Processor Comparison | March 2013 | June 2013 | |
| NCT03563352 | Withdrawn | Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer | August 30, 2018 | September 24, 2020 |
- Disase is a (Disease Ontology)
- DOID:1793
- Cross Reference ID (Disease Ontology)
- EFO:0002618
- Cross Reference ID (Disease Ontology)
- MESH:C562463
- Cross Reference ID (Disease Ontology)
- MIM:260350
- Cross Reference ID (Disease Ontology)
- NCI:C3850
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154475002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0235974
- Exact Synonym (Disease Ontology)
- carcinoma of pancreas
- Exact Synonym (Disease Ontology)
- Exocrine pancreas carcinoma
- Disase Synonym (Disease Ontology)
- exocrine cancer
- Disase Synonym (Disease Ontology)
- Pancreatic carcinoma, familial